Health Care Equipment & Services

Rossi Kasandra H’s recent restricted‑share grant at Pediatrix Medical Group signals strong insider confidence, underscoring PMGI’s solid growth prospects and strategic edge in pediatric healthcare.

Novocure insider sale: a routine RSU‑driven sell‑to‑cover at $15.77 shows no major market impact; focus on pipeline milestones for long‑term value.

Progyny CFO’s recent share sale shows routine insider activity—insights into liquidity, governance, and long‑term confidence in the company’s growth prospects.

Ber Gerard’s May 14 sale of Lantheus shares shows no market shift—insider confidence stays high, and the firm’s strong diagnostics pipeline suggests a good entry point near $100 before a potential rebound toward its 52‑week high.

Insider Gordon’s recent 298‑share purchase of Veeva Systems signals growing confidence in the company’s growth, reinforcing a bullish outlook ahead of earnings.

Insider sales of restricted shares by top executives raise questions about the company’s management sentiment, but solid fundamentals suggest the moves may be routine liquidity or tax planning rather than a shift in outlook.

Teladoc insiders surge: Rodrigues Fernando M. adds 15K shares, fueling bullish sentiment and media buzz—find out what this means for investors.

Insightful analysis of Hinge Health’s insider trades shows disciplined liquidity management, AI‑powered growth, and value‑based care positioning for investors.

Insulet Corp insider buys signal confidence amid volatility—examining WEATHERMAN’s recent purchase, market dynamics, and growth prospects for diabetes‑care investors.

June 1 insider sales at Pulmonx reveal routine tax‑settlement activity, highlighting the company’s thin liquidity, regulatory challenges and growth opportunities in bronchoscopic devices.